Post-IPO Equity - Corvus Pharmaceuticals
Investment Firm
Overview
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Announced Date
May 02, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
7
Round Details and Background
Corvus Pharmaceuticals raised $30600000 on 2024-05-02 in Post-IPO Equity
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 05, 2021 |  Post-IPO Equity - Corvus Pharmaceuticals | 2 | - | 10.0M |
| May 02, 2024 | Post-IPO Equity - Corvus Pharmaceuticals | 7 | - | 30.6M |
| Sep 25, 2015 | Series B - Corvus Pharmaceuticals | 6 | - | 75.0M |
| Dec 01, 2014 | Series A - Corvus Pharmaceuticals | 1 | - | 33.5M |